Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-24-008081
Filing Date
2024-03-01
Accepted
2024-02-29 17:46:10
Documents
4
Effectiveness Date
2024-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 ginkgo-sx82024evergreen.htm S-8 74502
2 EX-FILING FEES ginkgo-sx8filingfeetable20.htm EX-FILING FEES 40654
3 EX-5.1 ginkgos-8x51opinion2024eve.htm EX-5.1 8924
4 EX-23.1 eyconsent-sx8.htm EX-23.1 2507
  Complete submission text file 0001628280-24-008081.txt   127883
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277558 | Film No.: 24705519
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)